These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17684748)

  • 1. Partial remission of refractory RA after Adacolumn cytapheresis: a case report.
    Bazzichi L; Giuliano T; Rossi A; Mazzoni A; Grazzini T; De Feo F; Giacomelli C; Scatena F; Bombardieri S
    Rheumatol Int; 2008 Jan; 28(3):295-7. PubMed ID: 17684748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial.
    Sanmartí R; Marsal S; Valverde J; Casado E; Lafuente R; Kashiwagi N; Rodriguez-Cros JR; Erra A; Reina D; Gratacós J
    Rheumatology (Oxford); 2005 Sep; 44(9):1140-4. PubMed ID: 15927997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocytapheresis in the treatment of patients with rheumatoid arthritis.
    Ohara M; Saniabadi AR; Kokuma S; Hirata I; Adachi M; Agishi T; Kasukawa R
    Artif Organs; 1997 Sep; 21(9):989-94. PubMed ID: 9288869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study.
    Michelsen B; Kristianslund EK; Hammer HB; Fagerli KM; Lie E; Wierød A; Kalstad S; Rødevand E; Krøll F; Haugeberg G; Kvien TK
    Ann Rheum Dis; 2017 Apr; 76(4):708-711. PubMed ID: 27707730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
    Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
    Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluation of Adacolumn cytapheresis in healthy subjects.
    Ramlow W; Emmrich J; Ahrenholz P; Sparmann G; Kashiwagi N; Franz M; Yokoyama T; Yoshikawa T
    J Clin Apher; 2005 Jul; 20(2):72-80. PubMed ID: 15892085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission in rheumatoid arthritis by different criteria does not converge over the inflammatory markers.
    Chandrashekara S; Priyanka BU
    Int J Rheum Dis; 2013 Jun; 16(3):291-6. PubMed ID: 23981750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot clinical study of Adacolumn cytapheresis in patients with systemic lupus erythematosus.
    Soerensen H; Schneidewind-Mueller JM; Lange D; Kashiwagi N; Franz M; Yokoyama T; Ramlow W
    Rheumatol Int; 2006 Mar; 26(5):409-15. PubMed ID: 16189656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of rheumatoid arthritis in Spain (emAR II). Clinical characteristics of the patients.
    Maese J; García De Yébenes MJ; Carmona L; Hernández-García C;
    Reumatol Clin; 2012; 8(5):236-42. PubMed ID: 22608957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
    Sakata Y; Iwakiri R; Amemori S; Yamaguchi K; Fujise T; Otani H; Shimoda R; Tsunada S; Sakata H; Ikeda Y; Ando T; Nakafusa Y; Fujimoto K
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The provisional ACR/EULAR definition of remission in RA: a comment on the patient global assessment criterion.
    Vermeer M; Kuper HH; van der Bijl AE; Baan H; Posthumus MD; Brus HL; van Riel PL; van de Laar MA
    Rheumatology (Oxford); 2012 Jun; 51(6):1076-80. PubMed ID: 22302059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current topics on cytapheresis technologies.
    Yamaji K; Tsuda H; Hashimoto H
    Ther Apher; 2001 Aug; 5(4):287-92. PubMed ID: 11724514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First human application of a novel adsorptive-type cytapheresis module in patients with active ulcerative colitis: a pilot study.
    Ramlow W; Waitz G; Sparmann G; Prophet H; Bodammer P; Emmrich J
    Ther Apher Dial; 2013 Jun; 17(3):339-47. PubMed ID: 23735151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy, safety, and pharmacokinetic profiles of extended-release ketoprofen and piroxicam in patients with rheumatoid arthritis.
    Caldwell JR
    Clin Ther; 1994; 16(2):222-35. PubMed ID: 8062318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind comparison of etodolac and piroxicam in the treatment of rheumatoid arthritis.
    Dick WC; Franchimont P; Veys E
    Clin Ther; 1993; 15(1):148-59. PubMed ID: 8458044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.
    Luis M; Pacheco-Tena C; Cazarín-Barrientos J; Lino-Pérez L; Goycochea MV; Vazquez-Mellado J; Burgos-Vargas R
    Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
    de Punder YM; Fransen J; Kievit W; Houtman PM; Visser H; van de Laar MA; van Riel PL
    Rheumatology (Oxford); 2012 Sep; 51(9):1610-7. PubMed ID: 22539487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordance and accordance between patient's and physician's assessments in rheumatoid arthritis.
    Furu M; Hashimoto M; Ito H; Fujii T; Terao C; Yamakawa N; Yoshitomi H; Ogino H; Ishikawa M; Matsuda S; Mimori T
    Scand J Rheumatol; 2014; 43(4):291-5. PubMed ID: 24650255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of filtration leukocytapheresis(LCAP) in rheumatoid arthritis(RA)].
    Ueki Y; Takashima H; Matsumoto K; Miyake S; Hidaka T; Suzuki K; Eguchi K
    Nihon Rinsho; 2002 Dec; 60(12):2296-303. PubMed ID: 12510353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of half dose etanercept (25 mg once a week) on clinical remission and radiographic progression in patients with rheumatoid arthritis in clinical remission achieved with standard dose.
    Raffeiner B; Botsios C; Ometto F; Bernardi L; Stramare R; Todesco S; Sfriso P; Punzi L
    Clin Exp Rheumatol; 2015; 33(1):63-8. PubMed ID: 25535985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.